Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 33 (2) , 225-230
- https://doi.org/10.1016/0090-8258(89)90557-x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Chemotherapy for Cancer of the Cervix - Current Status and Its EvaluationAsia-Oceania Journal of Obstetrics and Gynaecology, 2010
- Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumorGynecologic Oncology, 1988
- Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervixBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Pelvic lymph node metastasis of uterine cervical cancerGynecologic Oncology, 1987
- The outcome of the patients with recurrent cervical carcinoma in terms of lymph node metastasis and treatmentGynecologic Oncology, 1987
- A possible new trend in the management of the carcinoma of the cervix uteriGynecologic Oncology, 1986
- V factor (tumor volume) and T factor (FIGO classification) in the assessment of cervix cancer prognosis: The risk of lymph node spreadGynecologic Oncology, 1985
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Cervical carcinoma: A drug-responsive tumor—experience with combined cisplatin, vinblastine, and bleomycin therapyGynecologic Oncology, 1983